Abstract
Understanding changes in infectiousness during COVID-19 infections is critical to assess the effectiveness of public health measures such as contact tracing. Data from known source-recipient pairs can be used to estimate the average infectiousness profile of infected individuals, and to evaluate the proportion of presymptomatic transmissions. Here, we infer the infectiousness profile of COVID-19 infections using a mechanistic approach, and show that this method provides an improved fit to data from source-recipient pairs compared to previous studies. Our results indicate a higher proportion of presymptomatic transmissions than previously thought, with many transmissions occurring shortly before symptom onset. High infectiousness immediately prior to symptom onset highlights the importance of contact tracing, even if contacts from a short time window before symptom onset alone are traced.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
WSH was funded by an EPSRC Excellence Award for his doctoral studies. RNT was funded by a Junior Research Fellowship from Christ Church, Oxford. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
No IRB approval needed.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
The transmission pair data used in our analyses are available in the Supplementary Materials. Code for reproducing our results is available at https://github.com/will-s-hart/COVID-19-Infectiousness-Profile.